Jia Xiang-Bo, Zhang Quan, Xu Lei, Yao Wen-Jian, Wei Li
Department of Thoracic Surgery, Zhengzhou Key Laboratory of Surgical Treatment for End-Stage Lung Diseases, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou 450003, Henan, People's Republic of China.
Onco Targets Ther. 2020 Jul 17;13:6987-6996. doi: 10.2147/OTT.S261033. eCollection 2020.
The aim of this study was to observe the preventive effect of flavonoids extracted from Nakai leaves (FMANL) on esophageal cancer in mice, especially the ability of FMANL to regulate the interleukin 17 (IL-17) signaling pathway during this process.
The C57BL/6J mice were treated with 4-nitroquinoline -oxide (4NQO) to induce esophageal cancer, and the visceral tissue index and the serum and esophageal tissue indexes of mice were used to verify the effect of FMANL.
The experimental results showed that FMANL can effectively control the changes in visceral tissue caused by esophageal cancer. FMANL could increase the cytokine levels of interleukin 10 (IL-10), monocyte chemotactic protein 1 (MCP-1) and decrease the cytokine levels of tumor necrosis factor alpha (TNF-α), interferon-γ (IFN-γ), interleukin 6 (IL-6), and interleukin 12p70 (IL-12p70) in serum of mice with esophageal cancer. FMANL could also reduce CD3, CD4, and CD8 and enhance CD19 mouse peripheral blood lymphocytes. The results of qPCR and Western blot analysis showed that FMANL could down-regulate the mRNA and protein expression levels of IL-17, interleukin 23 (IL-23), interleukin 1 beta (IL-1β), chemokine (C-X-C) ligand 1 (CXCL1), chemokine (C-X-C) ligand 2 (CXCL2), S100 calcium-binding protein A8 (S100A8), S100 calcium-binding protein A9 (S100A9), matrix metalloprotein 9 (MMP-9), and matrix metalloprotein 13 (MMP-1) in mice with esophageal cancer. High-performance liquid chromatography (HPLC) detection showed that FMANL contained 10 chemicals, including rutin, hyperoside, isoquercitrin, dihydroquercetin, quercitrin, hesperidin, myricetin, baicalin, neohesperidin dihydrochalcone, and quercetin.
It could be concluded that FMANL can effectively prevent experimentally induced esophageal cancer in mice, and its effects might be obtained from 10 compounds present in FMANL.
本研究旨在观察中井树叶中提取的黄酮类化合物(FMANL)对小鼠食管癌的预防作用,尤其是FMANL在此过程中调节白细胞介素17(IL-17)信号通路的能力。
用4-硝基喹啉氧化物(4NQO)处理C57BL/6J小鼠以诱导食管癌,并用小鼠的内脏组织指数以及血清和食管组织指标来验证FMANL的作用效果。
实验结果表明,FMANL可有效控制食管癌引起的内脏组织变化。FMANL可提高食管癌小鼠血清中白细胞介素10(IL-10)、单核细胞趋化蛋白1(MCP-1)的细胞因子水平,并降低肿瘤坏死因子α(TNF-α)、干扰素-γ(IFN-γ)、白细胞介素6(IL-6)和白细胞介素12p70(IL-12p70)的细胞因子水平。FMANL还可减少CD3、CD4和CD8,并增强CD19小鼠外周血淋巴细胞。qPCR和蛋白质印迹分析结果表明,FMANL可下调食管癌小鼠中IL-17、白细胞介素23(IL-23)、白细胞介素1β(IL-1β)、趋化因子(C-X-C)配体1(CXCL1)、趋化因子(C-X-C)配体2(CXCL2)、S100钙结合蛋白A8(S100A8)、S100钙结合蛋白A9(S100A9)、基质金属蛋白酶9(MMP-9)和基质金属蛋白酶13(MMP-1)的mRNA和蛋白质表达水平。高效液相色谱(HPLC)检测显示,FMANL含有10种化学成分,包括芦丁、金丝桃苷、异槲皮苷、二氢槲皮素、槲皮苷、橙皮苷、杨梅素、黄芩苷、新橙皮苷二氢查耳酮和槲皮素。
可以得出结论,FMANL可有效预防实验诱导的小鼠食管癌,其作用可能源于FMANL中存在的10种化合物。